# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001682852-23-000002
Filing Date
2023-01-03
Accepted
2023-01-03 07:05:38
Documents
17
Period of Report
2023-01-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | mrna-20230103.htm iXBRL | 8-K | 37611
2 | EX-99.1 | exhibit991-01032023lettert.htm | EX-99.1 | 41344
6 |  | image_01a.jpg | GRAPHIC | 236726
7 |  | image_0a.jpg | GRAPHIC | 29394
8 |  | image_1.jpg | GRAPHIC | 398434
9 |  | imagea.jpg | GRAPHIC | 2451
| Complete submission text file | 0001682852-23-000002.txt |  | 1146863

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mrna-20230103.xsd | EX-101.SCH | 1905
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mrna-20230103_lab.xml | EX-101.LAB | 23832
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mrna-20230103_pre.xml | EX-101.PRE | 12510
11 | EXTRACTED XBRL INSTANCE DOCUMENT | mrna-20230103_htm.xml | XML | 11354

Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

EIN.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38753 | Film No.: 23500179
SIC: 2836 Biological Products, (No Diagnostic Substances)